Insmed Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +84.7% | +23.0% | +19.0% | +66.4% | +111.0% | +39.0% | +0.2% | -27.2% | +2.4% | +4.1% | +49.4% | |
| – | +37.6% | +15.7% | +0.2% | +45.2% | +2.8% | +34.1% | +27.3% | +25.3% | +29.6% | +29.5% | +57.7% | |
| – | +37.5% | +15.7% | +0.2% | +57.4% | -5.2% | +34.1% | +96.5% | -34.9% | – | – | – | |
| – | -134.0% | – | +30.6% | +39.5% | -500.2% | – | – | – | -696.5% | – | – | |
| – | -35.5% | +21.6% | -28.5% | +393.6% | +185.3% | -83.9% | +6.8% | +35.5% | +34.5% | +65.0% | +48.5% | |
| – | -35.3% | +21.6% | -28.5% | +393.6% | +185.3% | -83.9% | +842.3% | -46.2% | +546.6% | +160.8% | -88.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +106.6% | -99.5% | +35,055.8% | -97.7% | +3,085.2% | -3.1% | +7.3% | +6.8% | – | – | – | |
| – | -105.3% | – | +1,235.0% | -4.3% | -100.2% | +0.0% | – | +3.3% | -100.4% | – | -103.3% | |
| – | +97.9% | -86.5% | +1,142.4% | +1.5% | -26.2% | -5.0% | +126.0% | +29.5% | -78.8% | +696.1% | -28.9% | |
| – | +172.8% | -197.3% | – | -47.9% | -106.7% | – | +306.0% | +94.1% | -265.6% | – | -161.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.